郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

病毒感染Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.

期刊:Vaccine发表年份:2022作者:Rik L de Swart; Olav S de Leeuw; Nadia Oreshkova; Nora M Gerhards; Irina C Albulescu; Sandra Vreman; José L Gonzales; Riks Maas; Frank J M van Kuppeveld; Peter Soema; Berend-Jan Bosch; Ben P H Peeters

病毒感染Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy.

期刊:Journal of biomedical science发表年份:2022作者:Chen-Yi Chiang; Mei-Yu Chen; Chia-Wei Hsu; Chia-Yeh Liu; Yu-Wen Tsai; Hung-Chun Liao; Jia-Ying Yan; Zih-Shiuan Chuang; Hsin-I Wang; Chien-Hsiung Pan; Chia-Yi Yu; Guann-Yi Yu; Ching-Len Liao; Shih-Jen Liu; Hsin-Wei Chen

病毒感染SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19.

期刊:Frontiers in cardiovascular medicine发表年份:2022作者:Margo Daems; Laurens Liesenborghs; Robbert Boudewijns; Steven J Simmonds; Sirima Kraisin; Jore Van Wauwe; Ilona Cuijpers; Jana Raman; Nadèche Geuens; Tina Van Buyten; Marleen Lox; Peter Verhamme; Sophie Van Linthout; Kimberly Martinod; Stephane Heyma

病毒感染Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152).

期刊:Frontiers in immunology发表年份:2022作者:Raju Sunagar; Sai D Prasad; Raches Ella; Krishna Mohan Vadrevu